UA37101A - METHOD OF COMPLEX TREATMENT OF PARANOID SCHIZOPHRENIA WITH SUICIDE BEHAVIOR - Google Patents

METHOD OF COMPLEX TREATMENT OF PARANOID SCHIZOPHRENIA WITH SUICIDE BEHAVIOR

Info

Publication number
UA37101A
UA37101A UA2000031591A UA200031591A UA37101A UA 37101 A UA37101 A UA 37101A UA 2000031591 A UA2000031591 A UA 2000031591A UA 200031591 A UA200031591 A UA 200031591A UA 37101 A UA37101 A UA 37101A
Authority
UA
Ukraine
Prior art keywords
haloperidol
paranoid schizophrenia
holiatry
durations
minutes
Prior art date
Application number
UA2000031591A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Петро Тодорович Петрюк
Петр Тодорович Петрюк
Original Assignee
Харківська Міська Клінічна Психіатрична Лікарня №15
Харьковская Городская Клиническая Психиатрическая Больница №15
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харківська Міська Клінічна Психіатрична Лікарня №15, Харьковская Городская Клиническая Психиатрическая Больница №15 filed Critical Харківська Міська Клінічна Психіатрична Лікарня №15
Priority to UA2000031591A priority Critical patent/UA37101A/en
Publication of UA37101A publication Critical patent/UA37101A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to medicine, namely to the psychiatry, and it may be used for the holiatry of paranoid schizophrenia with a suicidal behavior. A holiatry of paranoid schizophrenia with a suicidal behavior consists in that additionally on a background of peroral administration of haloperidol high doses in 4 hours after its morning peroral intake the haloperidol is intramuscularry administered at a dose of 10 mg and in 20-40 minutes the treatment is carried out by the method of electric sleep with a haloperidol according to oculoauricular mode with the permanent increase of current strength from 15 to 20 мА, impulse frequencies from 5 to 120 Hertzs, their durations from 0.2 to 0.5 мс, durations of procedure from 20 to 90 minutes at the treatment course of 15 daily procedures.
UA2000031591A 2000-03-21 2000-03-21 METHOD OF COMPLEX TREATMENT OF PARANOID SCHIZOPHRENIA WITH SUICIDE BEHAVIOR UA37101A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2000031591A UA37101A (en) 2000-03-21 2000-03-21 METHOD OF COMPLEX TREATMENT OF PARANOID SCHIZOPHRENIA WITH SUICIDE BEHAVIOR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2000031591A UA37101A (en) 2000-03-21 2000-03-21 METHOD OF COMPLEX TREATMENT OF PARANOID SCHIZOPHRENIA WITH SUICIDE BEHAVIOR

Publications (1)

Publication Number Publication Date
UA37101A true UA37101A (en) 2001-04-16

Family

ID=74181962

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000031591A UA37101A (en) 2000-03-21 2000-03-21 METHOD OF COMPLEX TREATMENT OF PARANOID SCHIZOPHRENIA WITH SUICIDE BEHAVIOR

Country Status (1)

Country Link
UA (1) UA37101A (en)

Similar Documents

Publication Publication Date Title
IL267381A (en) Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
DK0703786T3 (en) Use of nona- and decapeptides for the manufacture of a medicament for the treatment of AIDS
ATE338554T1 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATING ERECTILE DYSFUNCTION
TW200501983A (en) Uses of anti-insulin-like growth factor I receptor antibodies
EA200300503A1 (en) NEW MEDICINAL COMPOSITIONS BASED ON SALTS OF TIOTROPY AND SALTS OF SALMETEROL
EA200802159A1 (en) INTRODUCTION OF THE AGONIST-ANTAGONIST TO PATIENTS WITH OPIOID DEPENDENCE
DK1244438T3 (en) Use of beta-adrenoceptor antagonists in the manufacture of a medicament for the treatment of diseases of the outer retina
ATE347364T1 (en) QUETIAPINE FOR THE TREATMENT OF DYSKINESIA IN NON-PSYCHOTIC PATIENTS
UA37074A (en) METHOD OF THERAPY OF SIMPLE SCHIZOPHRENIA WITH SUICIDE BEHAVIOR
UA37100A (en) METHOD OF THERAPY OF PARANOID SCHIZOPHRENIA WITH SUICIDE BEHAVIOR
UA37065A (en) METHOD OF COMPLEX TREATMENT OF SIMPLE SCHIZOPHRENIA WITH SUICIDE BEHAVIOR
UA37144A (en) METHOD OF INTENSIVE THERAPY OF SIMPLE SCHIZOPHRENIA WITH SUICIDE BEHAVIOR
BG105984A (en) Osanetant in the treatment of mood disorders
EA200400386A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GAMMA-BUTYROBETAINE
DE60005548D1 (en) COMPOSITION CONTAINING AN EXTRACT OF PERNA CANALICULUS, METHYLSULFONYLMETHANE AND GLUCOSAMINE AND USE
UA36797A (en) method for intensive treatment of simple schizophrenia with suicide behaviour
UA37666A (en) METHOD OF COMPLEX THERAPY OF SIMPLE SCHIZOPHRENIA WITH SUICIDE BEHAVIOR
EA200100041A1 (en) METHOD OF TREATMENT
DK1161254T3 (en) Treatment of autoimmune diseases with an extract of American ginseng
DE60020550D1 (en) METHOD AND MEANS FOR TREATING A POST POLIOSYNDROME
UA36633A (en) method for treatment of paranoid schizophrenia with with suicide behaviour
FR2812549B1 (en) DALFOPRISTINE / QUINUPRISTINE ASSOCIATIONS WITH CEFPIROME
UA38381A (en) METHOD OF COMPLEX THERAPY OF DEPRESSIVE-PARANOID SYNDROME IN PATIENTS WITH SCHIZOPHRENIA
UA37717A (en) METHOD OF COMPLEX THERAPY OF SCHIZOPHRENIA WITH SUICIDE BEHAVIOR
UA38299A (en) METHOD OF INTENSIVE THERAPY OF DEPRESSIVE-PARANOID SYNDROME IN PATIENTS WITH SCHIZOPHRENIA